Experiment 1020512

Worktypes

EFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN HUMANS

Compounds isolated

LENTINAN

Alerts

RESULTS SIGNIFICANT AT P < 0.01 LEVEL.DATA INCOMPLETE - DERIVED FROM AN ABSTRACT.

Details

PropertyValue
Pharmacology
ANTITUMOR ACTIVITY
Administration routeIV
OrganismEmpty organism
CitationTAGUCHI,T: KIMURA,T: KONDOH,T: HATTORI,T: ITOH,I: OGAWI,N:. (1982). LIFE SPAN PROLONGATION EFFECT OF LENTINAN ON PATIENTS WITH ADVANCED OR RECURRENT GASTRIC CANCER.. 4(4)
Amount utilized
Compound isolated
DiseaseDOSING TWICE WEEKLY. IN COMBINATION WITH TEGAFUR.
Dose amount1.0 MG
Number2
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitPERSON
Dose expressionDOSE